ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

PTCT PTC Therapeutics Inc

34,09
0,52 (1,55%)
Após o horário de negociação
Última atualização: 19:40:56
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
PTC Therapeutics Inc PTCT NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,52 1,55% 34,09 19:40:56
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
34,09 33,62 34,56 34,09 33,57
mais cotações »

Notícias Recentes

Data Hora Fonte Título
25/07/202417:30PRNUSPTC Therapeutics to Host Conference Call to Discuss Second..
28/06/202407:00PRNUSCHMP Issues Negative Opinion on Translarna™ Following..
21/06/202417:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
20/06/202407:30PRNUSInterim PIVOT-HD Results Demonstrate Evidence of Favorable..
29/05/202409:00PRNUSPTC Therapeutics to Participate at Upcoming Investor..
28/05/202409:30PRNUSPTC Therapeutics Announces Validation of Sepiapterin..
20/05/202413:20PRNUSPTC Therapeutics Announces European Commission Returns..
20/05/202408:00PRNUSPTC Therapeutics Announces European Commission Returns..
14/05/202408:30PRNUSPTC Therapeutics Announces FDA Acceptance and Priority..
02/05/202409:00PRNUSPTC Therapeutics to Participate at Upcoming Investor..
25/04/202417:05PRNUSPTC Therapeutics Provides Corporate Update and Reports First..
23/04/202417:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
11/04/202409:00PRNUSPTC Therapeutics to Host Conference Call to Discuss First..
28/03/202409:30PRNUSPTC Announces Submission of Sepiapterin MAA for Treatment of..
19/03/202408:30PRNUSPTC Therapeutics Provides Key Regulatory Updates
29/02/202418:05PRNUSPTC Therapeutics Provides Corporate Update and Reports..
27/02/202419:20PRNUSPTC Therapeutics to Participate at Upcoming Investor..
22/02/202418:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
15/02/202410:00PRNUSPTC Therapeutics to Host Conference Call to Discuss Fourth..
25/01/202418:05PRNUSCHMP Issues Negative Opinion for Renewal of Conditional..
08/01/202411:26PRNUSPTC Therapeutics Provides an Update on Commercial Progress..
03/01/202410:00PRNUSPTC Therapeutics to Participate at 42nd Annual J.P. Morgan..
14/12/202318:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
05/12/202319:24DJNPTC Therapeutics Gives Updates on Translarna Regulatory..
05/12/202318:15PRNUSPTC Therapeutics Provides Updates on Translarna™ Regulatory..
03/11/202317:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
26/10/202317:05PRNUSPTC Therapeutics Provides Corporate Update and Reports Third..
19/10/202309:00PRNUSPTC Therapeutics Announces Evrysdi® Royalty Agreement with..
16/10/202317:30PRNUSPTC Therapeutics to Host Conference Call to Discuss Third..
29/09/202308:29IHMARKETNEWSFriday’s Wall Street Highlights: New Integrated, Nike,..
28/09/202321:12DJNStocks to Watch: Nike, Novo Integrated, PTC Therapeutics
28/09/202317:30PRNUSPTC Announces Further Strategic Prioritization and..
15/09/202307:00PRNUSCHMP Delivers Opinion on Translarna™ for Conversion to Full..
07/09/202309:00PRNUSPTC Therapeutics' 2023 STRIVE Awards Program Funds..
30/08/202309:00PRNUSPTC Therapeutics to Participate at Upcoming Investor..
28/08/202309:00PRNUSPTC Therapeutics to Present Recent Data for Sepiapterin at..
03/08/202317:01PRNUSPTC Therapeutics Provides Corporate Update and Reports..